Maximum but similar FABP3 expression was observed for 100 and 200 ng/ml of LPS, and accordingly, 100 ng/ml was chosen to be the experimental dose to evaluate the effect of loss of FABP3 on LPS-induced endothelial dysfunction. Here, FABP3 is linked to endothelial dysfunction.